bl-b01d1
biokin pharma
['bl-b01d1', 'nsclc', 'sclc']
bl-b01d1 the first bispecific antibody-drug conjugate targeting egfr &amp; her3
here, the focus in pretreated egfr mutant nsclc. an excellent perspective #asco23 
MD PhD, lung oncologist & researcher @IEOufficiale; @myESMO Communication Committee Chair; #LungCancer Molecular target-believer #LCSM